Followers | 129 |
Posts | 2150 |
Boards Moderated | 1 |
Alias Born | 12/27/2007 |
Thursday, May 26, 2016 1:54:47 PM
In April, AYTU signed an exclusive license agreement for the U.S. commercial rights to Natesto® (testosterone) Nasal Gel. Natesto is the first and only nasal formulation of testosterone approved by the U.S. Food and Drug Administration (FDA) as a replacement therapy for men diagnosed with hypogonadism (low testosterone, or “Low T”). Aytu anticipates further expanding its current urology-centric sales force and initiating its promotion of Natesto into the $2 billion U.S. testosterone replacement market in July 2016.
Aytu Bioscience (AYTU)
Market Cap: $13.5 Million
Cash: $15 Million
Price: $0.30
Shares Out: 44.86 Million
Marketed Products:
PRIMSOL : Only FDA-approved trimethoprim oral solution; indicated for urinary tract infections
ProstaScint : Only FDA-approved imaging agent for prostate cancerdetection and staging
MIOXSYS : CE Marked in vitro diagnostic device for male infertility , Single FDA study pending
Acquired Exclusive U.S. Rights to Natesto April 2016 (US Market Launch July)
•Only FDA-approved, nasally-administered testosterone; indicated for hypogonadism
•Approved for use WITHOUT black box warning related to partner transference
ZERTANE :Phase 3-ready, effective first-in-class oral treatment for premature ejaculation
Presentation May 2016
http://aytubio.com/downloads/Aytu-Corporate-Overview.pdf
Aytu BioScience Initiates Commercial Expansion to Support July 2016 Launch of Natesto®
http://finance.yahoo.com/news/aytu-bioscience-initiates-commercial-expansion-120500542.html
Insider Buying:
May 6, 2016 DISBROW JOSHUA R. Officer direct Buy 0.40 250,000
May 6, 2016 DISBROW JARRETT Officer direct Buy 0.40 250,000
May 6, 2016 DOCKERY CARL Director indirect Buy 0.40 5,000,000
Jan 20, 2016 DISBROW JOSHUA R. Officer direct Buy 0.65 153,846
Jan 20, 2016 DISBROW JARRETT Officer direct Buy 0.65 153,846
Recent AYTU News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:12:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:25:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:37:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:10:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:05:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:05:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/12/2023 06:50:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:37:00 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 08:20:15 PM
- Wednesday’s Wall Street Highlights: Amazon, Costco, Sirius XM, Electronic Arts, Peloton, and more • IH Market News • 09/27/2023 11:28:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 10:27:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 12:57:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:49:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:39:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:34:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:28:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:21:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:10:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 12:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 12:05:14 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM